Cite
HARVARD Citation
Sun, X. et al. (2016). A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer. BMC cancer. 16 (1), pp. 1-7. [Online].